The Market Reports

Index

1 Biosimilar Drug Market Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Biosimilar Drug Segment by Type
1.2.1 Global Biosimilar Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Segment by Application
1.3.1 Global Biosimilar Drug Sales Comparison by Application: (2021-2027)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Global Biosimilar Drug Market Size Estimates and Forecasts
1.4.1 Global Biosimilar Drug Revenue 2016-2027
1.4.2 Global Biosimilar Drug Sales 2016-2027
1.4.3 Biosimilar Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Biosimilar Drug Market Competition by Manufacturers
2.1 Global Biosimilar Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biosimilar Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type
2.5 Biosimilar Drug Market Competitive Situation and Trends
2.5.1 Biosimilar Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilar Drug Players Market Share by Revenue
2.5.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biosimilar Drug Retrospective Market Scenario by Region
3.1 Global Biosimilar Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Biosimilar Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Biosimilar Drug Market Facts & Figures by Country
3.3.1 North America Biosimilar Drug Sales by Country
3.3.2 North America Biosimilar Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilar Drug Market Facts & Figures by Country
3.4.1 Europe Biosimilar Drug Sales by Country
3.4.2 Europe Biosimilar Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilar Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilar Drug Sales by Region
3.5.2 Asia Pacific Biosimilar Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biosimilar Drug Market Facts & Figures by Country
3.6.1 Latin America Biosimilar Drug Sales by Country
3.6.2 Latin America Biosimilar Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilar Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilar Drug Sales by Country
3.7.2 Middle East and Africa Biosimilar Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biosimilar Drug Historic Market Analysis by Type
4.1 Global Biosimilar Drug Sales Market Share by Type (2016-2021)
4.2 Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
4.3 Global Biosimilar Drug Price by Type (2016-2021)

5 Global Biosimilar Drug Historic Market Analysis by Application
5.1 Global Biosimilar Drug Sales Market Share by Application (2016-2021)
5.2 Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
5.3 Global Biosimilar Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CP Guojian Pharma
6.1.1 CP Guojian Pharma Corporation Information
6.1.2 CP Guojian Pharma Description and Business Overview
6.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CP Guojian Pharma Biosimilar Drug Product Portfolio
6.1.5 CP Guojian Pharma Recent Developments/Updates
6.2 Biotech Pharma
6.2.1 Biotech Pharma Corporation Information
6.2.2 Biotech Pharma Description and Business Overview
6.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Biotech Pharma Biosimilar Drug Product Portfolio
6.2.5 Biotech Pharma Recent Developments/Updates
6.3 Celgen Pharma
6.3.1 Celgen Pharma Corporation Information
6.3.2 Celgen Pharma Description and Business Overview
6.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgen Pharma Biosimilar Drug Product Portfolio
6.3.5 Celgen Pharma Recent Developments/Updates
6.4 Henlius
6.4.1 Henlius Corporation Information
6.4.2 Henlius Description and Business Overview
6.4.3 Henlius Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Henlius Biosimilar Drug Product Portfolio
6.4.5 Henlius Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amgen Biosimilar Drug Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Eli Lilly Biosimilar Drug Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Biosimilar Drug Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Changchun High Tech
6.8.1 Changchun High Tech Corporation Information
6.8.2 Changchun High Tech Description and Business Overview
6.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Changchun High Tech Biosimilar Drug Product Portfolio
6.8.5 Changchun High Tech Recent Developments/Updates
6.9 Innovent
6.9.1 Innovent Corporation Information
6.9.2 Innovent Description and Business Overview
6.9.3 Innovent Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Innovent Biosimilar Drug Product Portfolio
6.9.5 Innovent Recent Developments/Updates

7 Biosimilar Drug Manufacturing Cost Analysis
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilar Drug
7.4 Biosimilar Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilar Drug Distributors List
8.3 Biosimilar Drug Customers

9 Biosimilar Drug Market Dynamics
9.1 Biosimilar Drug Industry Trends
9.2 Biosimilar Drug Growth Drivers
9.3 Biosimilar Drug Market Challenges
9.4 Biosimilar Drug Market Restraints

10 Global Market Forecast
10.1 Biosimilar Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilar Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biosimilar Drug by Type (2022-2027)
10.2 Biosimilar Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilar Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biosimilar Drug by Application (2022-2027)
10.3 Biosimilar Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilar Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biosimilar Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Biosimilar Drug Sales (K Dose) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biosimilar Drug Sales (K Dose) Comparison by Application (2021-2027)
Table 3. Global Biosimilar Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biosimilar Drug Covered in This Study
Table 5. Global Biosimilar Drug Sales (K Dose) of Key Manufacturers (2016-2021)
Table 6. Global Biosimilar Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Biosimilar Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biosimilar Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biosimilar Drug Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biosimilar Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilar Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilar Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 16. Global Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 17. Global Biosimilar Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 19. North America Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 20. North America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 23. Europe Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 27. Asia Pacific Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biosimilar Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biosimilar Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 31. Latin America Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 35. Middle East and Africa Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biosimilar Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Biosimilar Drug Sales (K Dose) by Type (2016-2021)
Table 39. Global Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 40. Global Biosimilar Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biosimilar Drug Revenue Share by Type (2016-2021)
Table 42. Global Biosimilar Drug Price (USD/Dose) by Type (2016-2021)
Table 43. Global Biosimilar Drug Sales (K Dose) by Application (2016-2021)
Table 44. Global Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 45. Global Biosimilar Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biosimilar Drug Revenue Share by Application (2016-2021)
Table 47. Global Biosimilar Drug Price (USD/Dose) by Application (2016-2021)
Table 48. CP Guojian Pharma Corporation Information
Table 49. CP Guojian Pharma Description and Business Overview
Table 50. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. CP Guojian Pharma Biosimilar Drug Product
Table 52. CP Guojian Pharma Recent Developments/Updates
Table 53. Biotech Pharma Corporation Information
Table 54. Biotech Pharma Description and Business Overview
Table 55. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Biotech Pharma Biosimilar Drug Product
Table 57. Biotech Pharma Recent Developments/Updates
Table 58. Celgen Pharma Corporation Information
Table 59. Celgen Pharma Description and Business Overview
Table 60. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Celgen Pharma Biosimilar Drug Product
Table 62. Celgen Pharma Recent Developments/Updates
Table 63. Henlius Corporation Information
Table 64. Henlius Description and Business Overview
Table 65. Henlius Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Henlius Biosimilar Drug Product
Table 67. Henlius Recent Developments/Updates
Table 68. Amgen Corporation Information
Table 69. Amgen Description and Business Overview
Table 70. Amgen Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Amgen Biosimilar Drug Product
Table 72. Amgen Recent Developments/Updates
Table 73. Eli Lilly Corporation Information
Table 74. Eli Lilly Description and Business Overview
Table 75. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Eli Lilly Biosimilar Drug Product
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Sandoz Corporation Information
Table 79. Sandoz Description and Business Overview
Table 80. Sandoz Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Sandoz Biosimilar Drug Product
Table 82. Sandoz Recent Developments/Updates
Table 83. Changchun High Tech Corporation Information
Table 84. Changchun High Tech Description and Business Overview
Table 85. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Changchun High Tech Biosimilar Drug Product
Table 87. Changchun High Tech Recent Developments/Updates
Table 88. Innovent Corporation Information
Table 89. Innovent Description and Business Overview
Table 90. Innovent Biosimilar Drug Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Innovent Biosimilar Drug Product
Table 92. Innovent Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Biosimilar Drug Distributors List
Table 96. Biosimilar Drug Customers List
Table 97. Biosimilar Drug Market Trends
Table 98. Biosimilar Drug Growth Drivers
Table 99. Biosimilar Drug Market Challenges
Table 100. Biosimilar Drug Market Restraints
Table 101. Global Biosimilar Drug Sales Forecast by Type (2022-2027) & (K Dose)
Table 102. Global Biosimilar Drug Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Biosimilar Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Biosimilar Drug Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Biosimilar Drug Sales Forecast by Application (2022-2027) & (K Dose)
Table 106. Global Biosimilar Drug Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Biosimilar Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Biosimilar Drug Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Biosimilar Drug Sales Forecast by Region (2022-2027) & (K Dose)
Table 110. Global Biosimilar Drug Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Biosimilar Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Biosimilar Drug Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilar Drug
Figure 2. Global Biosimilar Drug Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Market Share by Application in 2020 & 2027
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Global Biosimilar Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biosimilar Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Biosimilar Drug Sales 2016-2027 (K Dose)
Figure 15. Global Biosimilar Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Biosimilar Drug Sales Share by Manufacturers in 2020
Figure 17. Global Biosimilar Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Biosimilar Drug Players: Market Share by Revenue in 2020
Figure 19. Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Biosimilar Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Biosimilar Drug Sales Market Share by Region in 2020
Figure 22. Global Biosimilar Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Biosimilar Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Taiwan Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Biosimilar Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Biosimilar Drug by Type (2016-2021)
Figure 47. Sales Market Share of Biosimilar Drug by Application (2016-2021)
Figure 48. Sales Market Share of Biosimilar Drug by Application in 2020
Figure 49. Revenue Share of Biosimilar Drug by Application (2016-2021)
Figure 50. Revenue Share of Biosimilar Drug by Application in 2020
Figure 51. Manufacturing Cost Structure of Biosimilar Drug
Figure 52. Manufacturing Process Analysis of Biosimilar Drug
Figure 53. Biosimilar Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed